• BlueFive Capital closed a USD 3B Onyx Fund I, ADGM-registered, targeting technology and growth investments across the US and Europe.
• Backed by GCC sovereign capital, the fund focuses on AI, biotechnology, and advanced computing with scalable commercial applications globally today.
• It plans near-term US investments as it backs founders shaping inflection points in computational and biological intelligence across frontier sectors.

BlueFive Capital

UAE-based BlueFive Capital, a global investment firm, closed its USD 3 billion Onyx Fund I. The fund is registered with the Abu Dhabi Global Market (ADGM).  

The fund targets opportunistic technology and growth capital investments in the US and Europe. Furthermore, it will focus on innovative businesses in AI, biotechnology, and advanced computing, whose potential meets scalable commercial applications.

Founded in 2024, BlueFive Capital is a global investment platform that targets opportunities in high-growth economies. Its goal is to transform traditional financial models and foster sustainable growth. Furthermore, it aims to connect capital with high-impact opportunities across emerging and mature markets. It is registered with the Abu Dhabi Global Market and has offices in London, Manama, Abu Dhabi, Dubai, and Beijing. 

Investment

The fund has backing from opportunistic sovereign capital from across the GCC. This is in alignment with the region’s long-term investment priorities and high-conviction exposure to foundational technological disruption in Western markets. Furthermore, it expects to undertake several technology and biotechnology investments in the US in the coming months.

“The Onyx Fund aims to target the current inflection points in both computational and biological intelligence, allowing us to partner with visionary entrepreneurs who are defining the next technological epoch,” said Hazem Ben-Gacem, founder and chief executive of BlueFive Capital. 

Bottom line: BlueFive Capital’s USD 3 billion Onyx Fund signals rising GCC appetite for frontier technology exposure in US and European markets, anchored by sovereign capital.